c-Met immunohistochemistry as reflex test at diagnosis for non-small cell lung cancer: a real-world experience from a monocentric case series.

Christophe BontouxVeronique HofmanMilissa AbbouteVirginie Lespinet-FabreSalomé LalvéeSamantha GoffinetOlivier BordoneElodie Long-MiraSandra LassalleFlorent MurcyGuylène RignolSimon HeekeMarius IliePaul Hofman

Published in: Journal of clinical pathology (2023)

Systematic c-Met testing in daily routine for NSCLC patients is feasible, highlighting a potential correlation with clinicopathological and molecular features.

Keyphrases

end stage renal disease
small cell lung cancer
ejection fraction
newly diagnosed
chronic kidney disease
tyrosine kinase
prognostic factors
physical activity
peritoneal dialysis
clinical practice
risk assessment
patient reported outcomes
single molecule